JMLPH (ISSN Print 2788-9815, ISSN Online 2788-791X) is an interdisciplinary, peer-reviewed, fully open-access journal published by ARETION Publishing Group, London, in partnership with the Research Centre at the Second Healthcare Cluster (R2), Riyadh.

Yes — every article is published open access under a CC BY 4.0 licence. Authors retain full copyright; JMLPH receives right of first publication only.

Original research, systematic and narrative reviews, case reports, editorials, and policy analyses across medical law and ethics, public health policy, emergency and disaster medicine, digital health, reproductive medicine, antimicrobial resistance, nursing, occupational health, pain management, nutrition and NCDs, global health, and clinical specialties.

Every manuscript is evaluated by at least one national and one international expert. Author and reviewer identities are withheld from each other. Decisions rest solely on scientific merit, methodological quality, and ethical soundness.

A modest £70 article-processing charge applies to accepted articles. Authors from low-income and lower-middle-income countries (World Bank classification) are automatically exempt.

Initial assessment: 5–7 working days. Peer review: 3–4 weeks. Editorial decision: 1–2 weeks after reviews. Revision windows: 30–60 days.

Yes. Authors retain full copyright; JMLPH receives right of first publication only, under CC BY 4.0.

Every article receives a Crossref DOI and is indexed in the Directory of Open Access Journals (DOAJ), Google Scholar, OpenAlex, Semantic Scholar, BASE, Scilit, MIAR, EuroPub, ROAD, Ulrichsweb, Sherpa Romeo, Keepers Registry, EZB, WorldCat, Internet Archive, and multiple library discovery layers. Content is permanently archived via LOCKSS, CLOCKSS, and the Internet Archive.

Yes — prospective clinical trials should be registered in a WHO ICTRP–compliant registry or ClinicalTrials.gov before enrolment; the registration number must be cited in the manuscript.

Yes — all research articles should include a data availability statement describing whether and how the underlying data can be accessed.

Any generative-AI use must be disclosed in the methods section. AI tools cannot be listed as authors. Authorship is limited to those who meet ICMJE criteria.

Follow the EQUATOR Network guidance: CONSORT for randomised trials, STROBE for observational studies, PRISMA for systematic reviews and meta-analyses, and the appropriate equivalent for other designs.

Publishing open access under CC BY 4.0 helps meet most funder open-access requirements. Authors should check their specific funder policy for Plan S or equivalent compliance.

Submissions are handled through the OJS portal. Presubmission inquiries can be sent to the editorial office via the Contact page. Please review the Prepare Your Manuscript guidance before submitting.